Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2000, p. 2665-2669, Vol. 38, No. 7
Rush Medical College, Chicago, Illinois
606121; University of Southern
California, Los Angeles, California 900332;
Westat, Rockville, Maryland 208503;
New England Research Institutes, Watertown, Massachusetts
024724; Organon Teknika Corporation,
Durham, North Carolina 277125;
Department of Infectious Diseases, Roche Molecular Systems,
Inc., Alameda, California 945016; and
National Institute of Child Health and Human Development,
Bethesda, Maryland 208927
Received 28 January 2000/Returned for modification 3 April
2000/Accepted 9 May 2000
Human immunodeficiency virus type 1 (HIV-1) RNA levels in female
genital tract and peripheral blood samples were compared using two
commercial amplification technologies: the Roche AMPLICOR HIV-1 MONITOR
test and either the Organon Teknika nucleic acid sequence-based
amplification (NASBA-QT) assay or the NucliSens assay. Estimates of
HIV-1 RNA copy number were derived from internal kit standards and
analyzed unadjusted and adjusted to a common set of external standards.
We found a discordance rate of approximately 18% between the two
technologies for the detection of HIV-1 in either the genital tract or
peripheral blood samples. Detection discordance was not consistent
among specimens or among women. There were no significant differences
in adjusted or unadjusted estimates of HIV-1 RNA copy number in the
genital tract samples using the AMPLICOR HIV-1 MONITOR test and either
the NASBA-QT assay or the NucliSens assay. In addition, the estimated
HIV-1 RNA copy number in peripheral blood samples did not differ when tested with the NucliSens assay and the AMPLICOR HIV-1 MONITOR test
using kit standards. However, there was a significant difference in
estimated RNA copy number between the NASBA-QT assay and the AMPLICOR
HIV-1 MONITOR test for internal kit standards, which, as we have
previously shown, was eliminated after adjustment with the external
standards. Our results suggest that the Roche and Organon Teknika
assays are equivalent for quantifying HIV-1 RNA in female genital tract
specimens, although variation in detection does exist.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Comparison of Two Amplification Technologies for
Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA
in the Female Genital Tract
*
Corresponding author. Mailing address: Rush Medical
College, Chicago, IL 60612. Phone: (312) 942-3308. Fax: (312) 942-6787. E-mail: jbremer{at}rush.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|